Evaluation of JAK2V617F Mutation Prevalence in Myeloproliferative Neoplasm by AS-RT-PCR

Evaluation of JAK2V617F Mutation Prevalence in Myeloproliferative Neoplasm by AS-RT-PCR

Show other versions (1)

Background and Aim: The JAK2 is an acquired mutation that is observed in majority of patients with classical Philadelphia-negative Myeloproliferative neoplasms that include polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF). This acquired mutation is characterized by...

Full description

Bibliographic Details
Main Authors: B Bahar, H Dargahi, A Ghavamzadeh, K Alimoghdam, B Chahardouli, P Karimzadeh, H Ghafari, GH Togeh, F Nadali
Format: Article
Language:fas
Published: Tehran University of Medical Sciences 2009-11-01
Series:پیاورد سلامت
Subjects:
JAK2Mutation
Allele-Specific PCR
Chronic Myeloproliferative Neoplasms
CMPN
JAK2V617F Mutation
Polycythemia Vera
Essential Thrombocythemia
Primary Myelofibrosis
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/16726.pdf&manuscript_id=16726

Internet

http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/16726.pdf&manuscript_id=16726

Similar Items